Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 284.02M | 292.27M | 301.13M | 853.51M | 1.38B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 284.02M | 292.27M | 301.13M | 853.51M | 1.38B |
| Cost of Revenue | 165.32M | 164.78M | 163.56M | 583.80M | 994.50M |
| Gross Profit | 118.70M | 127.49M | 137.57M | 269.71M | 390.11M |
| SG&A Expenses | 116.25M | 106.63M | 111.58M | 203.76M | 291.45M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.08M | 3.14M | 7.53M | 2.88M | 6.93M |
| Total Operating Expenses | 282.65M | 274.55M | 282.67M | 790.44M | 1.29B |
| Operating Income | 1.37M | 17.72M | 18.46M | 63.07M | 91.73M |
| Income Before Tax | -112.56M | -49.45M | -16.11M | 85.87M | 93.45M |
| Income Tax Expenses | -15.98M | -6.86M | -6.17M | 6.99M | 4.35M |
| Earnings from Continuing Operations | -96.58 | -42.60 | -9.93 | 78.88 | 89.10 |
| Earnings from Discontinued Operations | -- | 23.67M | 39.77M | 39.77M | 39.77M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 44.00K | 184.00K | 234.00K |
| Net Income | -96.58M | -19.17M | 29.64M | 118.59M | 128.87M |
| EBIT | 1.37M | 17.72M | 18.46M | 63.07M | 91.73M |
| EBITDA | 12.95M | 29.72M | 65.82M | 144.03M | 205.76M |
| EPS Basic | -0.20 | -0.04 | 0.06 | 0.26 | 0.28 |
| Normalized Basic EPS | -0.09 | -0.02 | 0.02 | 0.07 | 0.12 |
| EPS Diluted | -0.20 | -0.03 | 0.07 | 0.26 | 0.28 |
| Normalized Diluted EPS | -0.09 | -0.02 | 0.02 | 0.07 | 0.12 |
| Average Basic Shares Outstanding | 1.93B | 1.90B | 1.89B | 1.87B | 1.85B |
| Average Diluted Shares Outstanding | 1.93B | 1.90B | 1.89B | 1.87B | 1.85B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -0.89% | 0.58% | 25.44% | 23.41% |